Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA grants tentative approval for Viatris’ pediatric HIV drug
FDA grants tentative approval for Viatris’ pediatric HIV drug
FDA grants tentative approval for Viatris’ pediatric HIV drug
Submitted by
admin
on September 5, 2023 - 8:53pm
Source:
Business Today
News Tags:
Viatris
FDA
HIV
pediatrics
abacavir
dolutegravir/lamivudine
Headline:
FDA grants tentative approval for Viatris’ pediatric HIV drug
snippet:
Viatris Inc. gains FDA tentative approval for abacavir/dolutegravir/lamivudine to treat paediatric HIV-1 patients.
WHO endorses the medication as a preferred treatment for paediatric HIV, highlighting a significant treatment gap for children with HIV
Do Not Allow Advertisers to Use My Personal information